ZPR1-Dependent Neurodegeneration Is Mediated by the JNK Signaling Pathway

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by mutations in the *SMN1* gene, leading to motor neuron degeneration.
• Zinc finger protein ZPR1 interacts with SMN and is crucial for its nuclear accumulation; reduced ZPR1 levels are observed in SMA patients and contribute to disease severity in mice.
• The precise mechanisms of ZPR1-dependent neurodegeneration remain largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying neurodegeneration caused by ZPR1 deficiency.
• To investigate the role of the c-Jun NH2-terminal kinase (JNK) signaling pathway in ZPR1-dependent neurodegeneration.

Main Methods:

• Utilized mouse models with reduced *Zpr1* gene dosage to study neurodegeneration.
• Investigated the activation of the MAPK signaling cascade (MLK3 → MKK7 → JNK3) in ZPR1-deficient neurons.
• Examined the effect of *Jnk3*-null mutations and pharmacologic JNK inhibition on ZPR1-dependent neurodegeneration.

Main Results:

• ZPR1 deficiency activates the MAPK signaling cascade, specifically the JNK3 pathway.
• This activation leads to the phosphorylation of c-Jun and subsequent caspase-mediated neuron degeneration.
• Neurons from *Jnk3*-null mice exhibited resistance to ZPR1-dependent neurodegeneration, and JNK inhibition reduced neuronal degeneration.

Conclusions:

• Neurodegeneration resulting from ZPR1 deficiency is mediated by the JNK signaling pathway, particularly the JNK3 isoform.
• Downregulation of ZPR1 in SMA may contribute to disease pathogenesis through JNK-mediated neurodegeneration.
• Targeting the JNK pathway presents a potential therapeutic strategy for SMA and related neurodegenerative conditions.